Furthermore, the loss of wild-type (wt) p53 function in clinical cancer specimens of prostate, melanoma and ovary has been revealed to be manifested by the lower level of THBS1 expression and enhanced tumor dissemination [36]. The gene discussed is TP53; the disease is neoplasm.